Zimmer Biomet to Acquire Paragon 28

Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28

Zimmer Biomet entered into a definitive agreement to acquire all outstanding shares of common stock of Paragon 28 for $13.00/share in cash, for an equity value of approximately $1.1 billion and an enterprise value of approximately $1.2 billion. The transaction is slated to close within the first half of 2025.

Paragon 28 offers a suite of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0